Pfizer has come back from the dead over the past couple of weeks, having previously served as a portfolio cash donor to purchase AI and internet security stocks.
All without the benefit of any new weight-loss drug.
There's certainly competing forces at work - some are betting on a pullback, while early indicator stocks like AAPL and GOOGL indicate that pullback is over.
Place your bets.
We've run out of other people's Social Security taxes needed to subsidize our low income tax rates.